scispace - formally typeset
A

Antoinette Lemoine

Researcher at French Institute of Health and Medical Research

Publications -  137
Citations -  12475

Antoinette Lemoine is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 43, co-authored 136 publications receiving 11416 citations. Previous affiliations of Antoinette Lemoine include University of Paris & UniverSud Paris.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Fabrice Barlesi, +31 more
- 02 Apr 2016 - 
TL;DR: The frequency of genetic alterations, acceptable turnaround times in obtaining analysis results, and the clinical advantage provided by detection of a genetic alteration suggest that this nationwide molecular profiling of patients with advanced NSCLC provides a clinical benefit.
Journal ArticleDOI

Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.

Daniel Azoulay, +7 more
- 01 Apr 2000 - 
TL;DR: PVE allows more patients with previously unresectable liver tumors to benefit from resection, and long-term survival is comparable to that after resection without PVE.
Journal ArticleDOI

Functions of autophagy in normal and diseased liver

Mark J. Czaja, +14 more
- 22 May 2013 - 
TL;DR: This review summarizes recent advances in understanding the roles that autophagy plays in normal hepatic physiology and pathophysiology with the intent of furthering the development of autophileagy-based therapies for human liver diseases.
Journal ArticleDOI

Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver.

Daniel Azoulay, +7 more
- 01 Nov 2000 - 
TL;DR: With the use of PVE, more patients with previously unresectable HCC in injured liver can benefit from resection, and long-term survival rates are comparable to those after resection without PVE.